Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $3 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.8% | 30.8% | 4.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.7% | 61.6% | 63.4% | 60.4% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -12.2% | -44.6% | -45.6% | 28.1% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -14.6% | -49.2% | -51.7% | 14.1% |
| EPS Diluted | -0.44 | -1.36 | -1.1 | 0.28 |
| % Growth | 67.6% | -23.6% | -492.9% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |